10-Q: Birchtech Narrows Losses, Eyes Water Market Amid Patent Wins

Sentiment:

Quarterly Report


Birchtech Corp. reported a significantly reduced net loss and operating loss for Q2 2025, driven by increased licensing revenue and lower operating expenses, while facing a going concern warning and strategic shifts into water treatment.

Capital raiseManagement is exploring additional financing opportunities to mitigate the company's financial condition and support its plans.
Better than expectedNet loss significantly decreased to $3.22 million for the six months ended June 30, 2025, from $9.00 million in the prior year, indicating improved financial performance.Operating loss improved to $2.53 million for the six months ended June 30, 2025, from $5.97 million in the prior year, reflecting better operational efficiency.License revenue saw a substantial increase to $525,000 for the six months ended June 30, 2025, from $140,625 in the prior year, contributing to higher gross margins.

Summary

  • Birchtech Corp. reported a net loss of $3.22 million for the six months ended June 30, 2025, a significant improvement from the $9.00 million net loss in the prior year period.
  • Operating loss also improved, decreasing to $2.53 million for the six months ended June 30, 2025, from $5.97 million in the same period last year.
  • Total revenues for the six months ended June 30, 2025, were $6.47 million, slightly down from $6.60 million in the prior year, primarily due to decreased product sales.
  • License revenue saw a substantial increase to $525,000 for the six months ended June 30, 2025, compared to $140,625 in the prior year, contributing to improved gross profit.
  • Cash and cash equivalents decreased to $1.45 million at June 30, 2025, from $3.46 million at December 31, 2024.
  • The company reported a working capital deficiency of $5.71 million at June 30, 2025, worsening from $2.71 million at December 31, 2024.
  • An accumulated deficit of $75.97 million was reported at June 30, 2025.
  • The company was awarded a $57.1 million patent infringement verdict in March 2024, with the court ruling against the defendants' implied license defense on June 10, 2025, and awaiting final judgment.
  • Birchtech has strategically entered the water treatment business, commissioning two new state-of-the-art laboratory facilities in Pennsylvania and North Dakota.
  • A share repurchase program of up to $5.0 million was authorized in March 2025, with repurchases anticipated not before the second half of 2025.

Sentiment

Score: 6

Explanation: The sentiment is cautiously optimistic. While Birchtech demonstrated significant improvements in reducing net and operating losses, driven by increased licensing revenue and reduced SG&A, and achieved a major patent litigation victory, the company still faces a 'going concern' warning due to low cash reserves and a worsening working capital deficiency. The strategic pivot into the water treatment market is promising, but its revenue contribution is nascent. Regulatory uncertainty in the legacy mercury emissions business and identified internal control weaknesses temper the positive developments, indicating high risk despite potential upside.

Positives

  • Net loss significantly decreased to $3.22 million for the six months ended June 30, 2025, from $9.00 million in the prior year.
  • Operating loss improved to $2.53 million for the six months ended June 30, 2025, from $5.97 million in the prior year.
  • License revenue increased substantially to $525,000 for the six months ended June 30, 2025, from $140,625 in the prior year, indicating successful monetization of intellectual property.
  • Gross profit slightly increased to $2.20 million for the six months ended June 30, 2025, from $2.19 million in the prior year, driven by higher-margin licensing revenues.
  • Selling, general and administrative expenses decreased significantly to $3.87 million for the six months ended June 30, 2025, from $8.16 million in the prior year, primarily due to lower bonus compensation and legal fees.
  • The company secured a $57.1 million patent infringement verdict in March 2024, with a favorable court ruling on implied license defense on June 10, 2025, moving closer to potential cash inflows.
  • Successful debt restructuring in February and August 2024 eliminated secured and unsecured notes, reducing the profit participation preference from $17.7 million to $7.9 million, which is non-recourse and tied to litigation proceeds.
  • Strategic entry into the water treatment business with two new state-of-the-art laboratories positions the company for a new revenue stream.
  • Authorization of a share repurchase program for up to $5.0 million signals management's confidence and potential for shareholder value return.

Negatives

  • The company had a net loss of $3.22 million and cash used in operating activities of $1.99 million for the six months ended June 30, 2025, raising substantial doubt about its ability to continue as a going concern.
  • Cash and cash equivalents decreased significantly to $1.45 million at June 30, 2025, from $3.46 million at December 31, 2024.
  • Working capital deficiency worsened to $5.71 million at June 30, 2025, from $2.71 million at December 31, 2024.
  • Accumulated deficit increased to $75.97 million at June 30, 2025, from $72.75 million at December 31, 2024.
  • Product revenue decreased to $5.92 million for the six months ended June 30, 2025, from $6.39 million in the prior year, attributed to changes in plant operations and product mix.
  • Research and development expenses increased to $862,161 for the six months ended June 30, 2025, from $0 in the prior year, reflecting new investments but also increased costs.
  • The profit share liability (related party) increased to $7.58 million at June 30, 2025, from $6.85 million at December 31, 2024, due to changes in fair value.
  • Material weaknesses in internal control over financial reporting were identified, including a lack of sufficient personnel and insufficient written documentation of policies and procedures.

Risks

  • Substantial doubt exists about the company's ability to continue as a going concern due to recurring losses, negative cash flows from operations, and a working capital deficiency.
  • Dependence on receiving additional cash inflows from the $57.1 million jury verdict, which is still awaiting final judgment and subject to potential appeals or delays.
  • Uncertainty regarding additional licensing revenues and product sales from recently commenced patent litigation, as success is not assured and litigation is inherently unpredictable.
  • Risks related to the development and growth of new water treatment technologies, including market adoption and commercialization timelines.
  • Changes in general economic and business conditions could adversely affect demand for the company's products and services.
  • Regulatory changes and competitive pressures in the mercury emissions control and water treatment industries pose ongoing risks.
  • The potential loss of major customers or dependence on key suppliers could significantly impact operations.
  • Risks related to intellectual property, including the ability to protect patents and the success of any patent litigation, such as Inter Partes Review petitions seeking to invalidate claims.
  • Changes in demand for coal as a fuel source for electricity production could impact the legacy mercury emissions business.
  • Ability to retain key personnel is crucial for both existing operations and new business development.
  • Share price volatility is a risk, and there is no assurance that dividends will ever be declared.
  • The company's plans to mitigate going concern doubt, including additional financing opportunities, may not be successfully realized or implemented.

Future Outlook

Management believes that receiving additional cash inflows from the $57.1 million jury verdict, securing additional licensing revenues and product sales from ongoing patent litigation, and generating revenues from the new water treatment business will mitigate the company's financial condition over the next twelve months. The company is also actively exploring additional financing opportunities. Planned commercial thermal reactivation plants are expected to be opened and operated in the future, leveraging data from the new Design Centers to define permitting, capital expenditure, and operating costs.

Management Comments

  • Management believes its cash and financial resources may be insufficient to meet anticipated needs for the next twelve months, raising substantial doubt about the company's ability to continue as a going concern.
  • Management believes that plans including cash inflows from the $57.1 million jury verdict, additional licensing revenues, product sales from new patent litigation, and revenues from the water treatment business will alleviate substantial doubt, though there is no assurance of successful realization.
  • Management is exploring additional financing opportunities to support the company's financial condition.
  • The company views patent litigation as a last resort, with the goal and overall strategy being to convert infringers to its supply chain of sorbent products or license its patents on a non-exclusive basis.
  • The company believes its new Design Centers for water treatment innovation represent the only known facilities in North America with integrated capability to thermally reactivate spent granular activated carbon (GAC) and conduct rapid small-scale column tests (RSSCTs).
  • The company believes its technology platform is not solely dependent on PFAS regulations, as market demand for improved water treatment solutions is broad.
  • Management anticipates that any share repurchases will not occur before the second half of 2025 at the earliest, or until 2026, if at all.

Industry Context

Birchtech operates in the mercury emissions control market for coal-fired utilities, which is heavily influenced by federal regulations like the Mercury and Air Toxics Standards (MATS). Recent regulatory shifts under the Trump Administration, including a Presidential Proclamation exempting certain power plants from the 2024 updated MATS Rule and EPA proposals to repeal MATS amendments, introduce significant uncertainty and potential headwinds for the company's legacy business. Concurrently, Birchtech is pivoting into the rapidly growing water treatment market, specifically targeting 'forever chemicals' like PFAS and PFOS, driven by new national enforceable drinking water standards issued by the EPA. This strategic move positions the company in a high-demand sector, though the regulatory landscape for PFAS is also subject to potential changes under the new administration, with intentions to extend compliance deadlines and reconsider certain PFAS regulations. The company's investment in advanced lab facilities aims to capitalize on this emerging market by offering sustainable and cost-effective water treatment solutions.

Comparison to Industry Standards

  • NA

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Executive Director of Innovation and CommercializationNADavid Mazyck2025-06-01Appointment to head the new water treatment business line.
Director of National SalesNADennis Baranik2024-05-01Appointment to oversee product sales and IP licensing in core business and support water market development.
Director of Strategic OperationsNAChristopher Rinaldi2025-06-01Appointment with a focus on the water treatment business.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Equity Incentive Plan AmendmentsThe Board approved and adopted Amended and Restated 2014 and 2017 Equity Incentive Plans on July 3, 2023, and non-material amendments on October 29, 2024, in connection with TSX listing.2023-07-03Aligns plans with TSX Venture Exchange and Toronto Stock Exchange requirements, impacting share issuance for compensation.
Share Repurchase Program AuthorizationThe Board of Directors authorized a share repurchase program for up to $5.0 million of common stock on March 19, 2025.2025-03-19Provides flexibility for capital allocation and potential return of value to shareholders, subject to market conditions and liquidity.
Internal Control WeaknessesIdentified material weaknesses in internal control over financial reporting due to lack of sufficient personnel and insufficient written documentation/training of policies and procedures.2025-06-30Indicates a risk to the reliability of financial reporting, though management believes financial statements are fairly presented.

Legal Proceedings

  • A federal jury returned a $57.1 million verdict in favor of the company on March 1, 2024, against CERT defendants for willful patent infringement related to mercury emissions control.
  • On June 10, 2025, the Court ruled that the CERT defendants failed to prove they had an implied license and denied their motion to alter or amend the non-final judgment, with final judgment still pending.
  • The company commenced three additional patent infringement lawsuits in July 2024 in Arizona, Iowa, and Missouri against multiple utilities and related entities.
  • In October 2024 and January 2025, the company entered into non-exclusive license agreements with two Arizona utility defendants, receiving one-time license fees and securing rights for future product supply bidding.
  • On December 17, 2024, the U.S. Judicial Panel on Multidistrict Litigation ordered the consolidation of the three new lawsuits in the U.S. District Court for the Southern District of Iowa.
  • An additional infringement suit initiated in January 2025 against Evergy-affiliated entities in Western District of Missouri was transferred to the Iowa court in February 2025.
  • Certain defendants in the consolidated Iowa actions filed Inter Partes Review petitions with the U.S. Patent and Trademark Office in January and February 2025, seeking to invalidate various asserted claims.
  • Effective August 5, 2025, the company entered into separate non-exclusive license agreements with two affiliated Iowa utilities, including one-time license fees and rights to be included in future product supply bidding processes.

Related Party Transactions

  • The company incurred $225,000 in legal services and disbursements from Kaye Cooper Kay & Rosenberg, LLP for the six months ended June 30, 2025; David M. Kaye, a Director, is a partner at the firm. $37,500 was owed to the firm at June 30, 2025.
  • The company had a License and Supply Agreement with Dakin Holdings Ltd., a company owned and controlled by the company's Chief Executive Officer and President. Monthly license fees ceased after September 30, 2024, following an amendment in November 2024.
  • The company's profit share liability of $7,582,906 at June 30, 2025, is a non-recourse profit participation preference owed to AC Midwest Energy, LLC, which is wholly-owned by a stockholder of the company. This liability is payable only from net litigation proceeds.

Stakeholder Impact

  • Shareholders face potential share price volatility due to the company's going concern warning, reliance on litigation proceeds, and regulatory changes, but may benefit from the authorized share repurchase program and long-term growth in the water treatment sector.
  • Employees are impacted by the company's financial condition and the need for key personnel retention, with stock-based compensation being a component of their remuneration.
  • Customers in the mercury emissions control sector may experience changes in regulatory compliance requirements due to EPA policy shifts, potentially affecting demand for the company's products.
  • Suppliers face concentration risk, as 91% of the company's purchases for the six months ended June 30, 2025, related to two suppliers, though the company believes alternatives exist.
  • Creditors, particularly AC Midwest Energy, LLC, are impacted by the non-recourse nature of the profit share liability, which is dependent on future litigation proceeds.

Next Steps

  • The company is awaiting the Court's determination as to the final judgment regarding the $57.1 million patent infringement verdict.
  • The public comment period for the EPA's proposal to repeal certain May 2024 MATS Rule amendments is scheduled to close in August 2025.
  • The share repurchase program, authorized for up to $5.0 million, is anticipated to commence not before the second half of 2025, or potentially in 2026.
  • The company plans to open and operate commercial thermal reactivation plants in the future, leveraging data from its new Design Centers.
  • Ongoing patent infringement lawsuits in Iowa and Missouri will continue against non-affiliated defendants, with Inter Partes Review petitions pending.

Key Dates

DateDescription
2011-05-01U.S. Environmental Protection Agency (EPA) proposed the Mercury and Air Toxics Standards (MATS) rule.
2012-04-01EPA MATS rule became effective.
2014-01-10The 2014 Equity Incentive Plan was first approved by the Board.
2015-07-01Company entered into a five-year lease for warehouse space in Corsicana, Texas.
2016-11-01Restated financing agreement entered with AC Midwest Energy, LLC.
2016-11-29Company closed on a secured note and an unsecured note with AC Midwest.
2017-02-09The 2017 Equity Incentive Plan was adopted by the Board.
2017-04-28The 2014 Equity Incentive Plan was terminated by the Board, replaced by the 2017 Plan.
2018-12-15Original maturity date of the AC Midwest Secured Note.
2019-02-25Amendment No. 3 to the Amended and Restated Financing Agreement extended the AC Midwest Secured Note maturity to August 25, 2022; Unsecured Note Financing Agreement issued the AC Midwest Unsecured Note.
2019-06-01Warehouse lease extended to March 31, 2024.
2019-07-01Company initiated patent litigation against various defendants in the U.S. District Court for the District of Delaware.
2020-12-15Original maturity date of the AC Midwest Subordinated Note.
2020-07-01Company entered into agreements with major utility defendants in patent litigation (through January 2021).
2021-01-01Company entered into agreements with major utility defendants in patent litigation (from July 2020).
2022-08-25Extended maturity date of the AC Midwest Secured Note and AC Midwest Unsecured Note.
2022-08-30AC Midwest agreed to extend the maturity date of the AC Midwest Unsecured Note and Secured Note to September 30, 2022.
2022-09-28AC Midwest agreed to an additional short-term extension of the maturity date to October 31, 2022.
2022-10-28Amendment No. 4 to the Amended and Restated Financing Agreement extended the AC Midwest Secured Note maturity to August 25, 2025; Amendment No. 1 to Unsecured Note Financing Agreement extended the AC Midwest Unsecured Note maturity to August 25, 2025, and increased the Profit Share to $17,654,931.
2022-11-08Company issued 3,000,000 shares of common stock to the Chief Executive Officer.
2023-01-01Effective date of the License and Supply Agreement with Dakin Holdings Ltd.
2023-01-31Company entered into a License and Supply Agreement with Dakin Holdings Ltd.
2023-04-01EPA issued a proposal to strengthen and update MATS.
2023-07-03Board of Directors approved and adopted the Amended and Restated 2014 and 2017 Equity Incentive Plans.
2023-11-01Company entered into a confidential binding term sheet with Arthur J. Gallagher & Co. and DTE Energy Resources LLC to resolve patent litigation; Alistar Enterprises, LLC entered into a settlement agreement.
2023-12-01Company entered into a paid license of U.S. Patents with Chem-Mod LLC, Arthur J. Gallagher & Co., and DTE Energy Co.
2024-01-15Company granted nonqualified stock options to acquire 1,000,000 shares and 50,000 restricted share units (RSUs).
2024-02-01Case proceeded to trial in February 2024 against the remaining CERT defendants.
2024-02-27Company entered into an Unsecured Debt Restructuring Agreement with AC Midwest, paid down unsecured note, and repaid secured note in full; issued 9,285 shares upon cashless exercise of an option.
2024-03-01A federal jury returned a $57.1 million verdict in favor of the Company against the remaining CERT defendants.
2024-03-11Private sale of shares for $960,000 was completed, providing a credit toward the unsecured note.
2024-03-28Warehouse lease was further extended for an additional five years from March 31, 2024, to March 31, 2029.
2024-04-01Company announced the introduction of its new water treatment business; EPA under the Biden Administration issued the first-ever national, enforceable drinking water standard for PFAS.
2024-05-01EPA finalized and published the strengthened and updated MATS proposal with an effective date of July 8, 2024; Company announced the appointment of David Mazyck and Dennis Baranik.
2024-06-24Company issued shares upon cashless exercise of options to CEO and Senior Vice President and Chief Technology Officer.
2024-06-28Company issued shares upon cashless exercise of options to employees and a former employee.
2024-07-01Company commenced three additional patent infringement lawsuits in U.S. District Courts in Arizona, Iowa, and Missouri.
2024-07-08Effective date of the 2024 updated MATS Rule.
2024-08-01Company entered into a 3-year lease for laboratory space in Grand Forks, North Dakota.
2024-08-03Company issued shares upon cashless exercise of an option to a former consultant.
2024-08-26Company repaid the remaining principal balance on the New Note together with accrued interest (completed by August 27, 2024).
2024-08-27New Note Maturity Date; Company repaid the remaining principal balance on the New Note together with accrued interest (started August 26, 2024).
2024-09-30Monthly license fees to Dakin Holdings Ltd. ceased after this date.
2024-10-09Company received conditional approval to list shares on the Toronto Stock Exchange (TSX).
2024-10-17Midwest Energy Emissions Corp. changed its corporate name to Birchtech Corp.; common stock commenced trading under ticker symbol BCHT.
2024-10-29Board approved non-material amendments to the 2014 and 2017 Equity Incentive Plans.
2024-11-08Shares issued to the Chief Executive Officer on November 8, 2022, became fully vested.
2024-11-12Company's shares commenced trading on the TSX under the ticker symbol BCHT.
2024-11-18Amendment to the Dakin Agreement eliminated all further monthly license fees after September 30, 2024.
2024-11-22Company entered into an approximate 3-year lease for laboratory space in State College, Pennsylvania.
2024-11-30State College lab lease ends (initial term).
2024-12-15State College lab lease commenced.
2024-12-17U.S. Judicial Panel on Multidistrict Litigation ordered consolidation of three lawsuits in the U.S. District Court for the Southern District of Iowa.
2024-12-30New director elected to the Board.
2024-12-31Facilitation Credit expired.
2025-01-01Investor relations consulting agreement effective.
2025-01-02Company granted a nonqualified stock option to a nonaffiliated third party consultant.
2025-01-09Company granted a nonqualified stock option to a new director.
2025-01-1550,000 RSUs vested, and 50,000 shares of common stock were issued to a director.
2025-02-01Certain defendants in the consolidated Iowa actions filed Inter Partes Review petitions (through February 2025).
2025-03-12Newly appointed EPA administrator under the Trump Administration announced plans to roll back dozens of environmental regulations, including reconsideration of the MATS regulation.
2025-03-19Company announced that its Board of Directors authorized a share repurchase program.
2025-04-08President Trump signed a Proclamation exempting certain stationary sources from compliance with the 2024 updated MATS Rule for two years.
2025-05-14EPA under the new Trump Administration announced it will keep regulations for PFOA and PFOS, extend compliance deadlines, and establish a federal exemption framework, while intending to rescind/reconsider other PFAS regulations.
2025-06-10The Court ruled that the CERT defendants failed to prove they had an implied license and denied their motion to alter or amend the non-final judgment.
2025-06-11EPA proposed to repeal certain amendments made to the MATS Rule published in May 2024, and return compliance obligations to prior standards.
2025-06-20Company issued shares upon cashless exercise of options to CEO and Senior Vice President and Chief Technology Officer.
2025-06-30End of the quarterly period covered by this report.
2025-07-31Grand Forks lab lease rent increases.
2025-08-05Company entered into separate agreements with two affiliated utilities named as defendants in the Southern District of Iowa action.
2025-08-14Date of filing of this Quarterly Report on Form 10-Q; Shares outstanding as of this date.
2025-08-01Public comment period for EPA proposal to repeal MATS amendments scheduled to close.
2025-11-30State College lab lease rent increases.
2025-12-31Dakin Agreement license fee period ends.
2026-03-31Warehouse lease rent increases.
2026-11-30State College lab lease rent increases.
2027-07-08Start of two-year exemption period for certain stationary sources from 2024 updated MATS Rule.
2027-07-31Grand Forks lab lease ends (initial term).
2027-11-30State College lab lease ends (initial term).
2028-11-30State College lab lease rent increases (option period).
2029-03-31Warehouse lease ends.
2029-07-08End of two-year exemption period for certain stationary sources from 2024 updated MATS Rule.
2029-11-30State College lab lease rent increases (option period).
2030-07-31Grand Forks lab lease ends (with option).
2030-11-30State College lab lease ends (with option).

Recommendation

hold

Birchtech Corp. presents a mixed financial picture. While the company significantly reduced its net and operating losses, driven by increased licensing revenue and reduced SG&A, and secured a substantial patent infringement verdict, it faces a 'going concern' warning due to declining cash and a worsening working capital deficiency. The strategic expansion into the water treatment market and recent licensing agreements from litigation offer long-term growth potential. However, regulatory uncertainty in the legacy mercury emissions business and identified material weaknesses in internal controls introduce considerable risk. Existing investors may hold given the potential upside from litigation proceeds and the new business segment, but new investment carries high risk due to the immediate financial challenges and reliance on future events.

Keywords

Birchtech, BCHT, mercury emissions control, water purification, PFAS, PFOS, activated carbon, patent litigation, environmental technology, SEC filing, 10-Q, financial results, corporate governance, risk management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.